<DOC>
	<DOCNO>NCT01955811</DOCNO>
	<brief_summary>Patients need platelet transfusion reason participate study . Directly start infusion one hour end platelet transfusion blood sample draw treat different concentration Fibrinogen ( blood clot factor ) in-vitro . Blood sample without Fibrinogen/platelet transfusion compare . The study hypothesis treatment Fibrinogen result good stabilisation blood coagulation .</brief_summary>
	<brief_title>Study Reveal Fibrinogen Treatment Effects Blood Clotting Better Than Platelet Transfusion</brief_title>
	<detailed_description>In total 300 patient need platelet transfusion whatever reason include meeting inclusion- exclusion criterion . For patient three visit plan , blood sample take . The first blood sample take directly start platelet transfusion , second 1 hour end platelet transfusion third 24 hour . Untreated citrate EDTA blood sample Visit 1 serve baseline coagulation test . Further citrate blood sample first visit spike different concentration fibrinogen vitro . Untreated citrate EDTA blood sample take 1 hour 24 hour platelet transfusion comparison . Further citrate blood sample spike different concentration fibrinogen vitro 1 hour platelet transfusion . In addition , randomly choose sample analyze use confocal microscopy . Routine coagulation analysis include activate partial thromboplastin time ( aPTT ) , prothrombin time ( PT ) , fibrinogen , blood coagulation factor thirteen ( FXIII ) , thromboelastometry ( ExTEM &amp; FibTEM ) platelet transfusion .</detailed_description>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>patient clinical need platelet transfusion age : 18 85 year pregnant nursing woman patient disagree participate study emergency patient : patient know refusal participation clinical trial active participation clinical trial condition , include presence laboratory abnormality , would place confound ability interpret data study serious medical condition , laboratory abnormality , psychiatric illness , would prevent subject signing informed consent form</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>platelet transfusion</keyword>
	<keyword>Fibrinogen</keyword>
	<keyword>blood coagulation</keyword>
	<keyword>Thrombocytopenia</keyword>
	<keyword>in-vitro experiment</keyword>
	<keyword>FGTW</keyword>
	<keyword>Fit2012</keyword>
	<keyword>factor I</keyword>
	<keyword>Fibrin</keyword>
</DOC>